These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21524382)

  • 21. Redefining approaches to asthma: developing targeted biologic therapies.
    Arron JR; Scheerens H; Matthews JG
    Adv Pharmacol; 2013; 66():1-49. PubMed ID: 23433454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Many asthma patients experience persistent symptoms despite appropriate clinical and guideline-based treatment with inhaled corticosteroids.
    Mogil J
    J Am Acad Nurse Pract; 2007 Sep; 19(9):459-70. PubMed ID: 17760570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Omalizumab in the treatment of severe asthma: efficacy and current problems.
    Pelaia G; Renda T; Romeo P; Busceti MT; Maselli R
    Ther Adv Respir Dis; 2008 Dec; 2(6):409-21. PubMed ID: 19124386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Individual cytokines contributing to asthma pathophysiology: valid targets for asthma therapy?
    Chung KF
    Curr Opin Investig Drugs; 2003 Nov; 4(11):1320-6. PubMed ID: 14758771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MEDI-528, an anti-IL-9 humanized antibody for the treatment of asthma.
    Antoniu SA
    Curr Opin Mol Ther; 2010 Apr; 12(2):233-9. PubMed ID: 20373267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative agents in asthma.
    Frew AJ; Plummeridge MJ
    J Allergy Clin Immunol; 2001 Jul; 108(1):3-10. PubMed ID: 11447376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overcoming steroid insensitivity in smoking asthmatics.
    Ahmad T; Barnes PJ; Adcock IM
    Curr Opin Investig Drugs; 2008 May; 9(5):470-7. PubMed ID: 18465656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New therapeutic strategies in bronchial asthma].
    Goţia S; Hermeziu B
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(3):491-6. PubMed ID: 15832961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of histamine on Th1/Th2 cytokine balance.
    Packard KA; Khan MM
    Int Immunopharmacol; 2003 Jul; 3(7):909-20. PubMed ID: 12810348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.
    Nowak D
    Respir Med; 2006 Nov; 100(11):1907-17. PubMed ID: 16949266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokine-directed therapy in asthma.
    Ichinose M; Barnes PJ
    Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):263-9. PubMed ID: 15379594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyond.
    Calzetta L; Rogliani P; Cazzola M; Matera MG
    Expert Opin Drug Discov; 2014 Jun; 9(6):595-607. PubMed ID: 24749518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging monoclonal antibodies as targeted innovative therapeutic approaches to asthma.
    Mitchell PD; El-Gammal AI; O'Byrne PM
    Clin Pharmacol Ther; 2016 Jan; 99(1):38-48. PubMed ID: 26502193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic potential of targeting interleukin 5 in asthma.
    Walsh GM
    BioDrugs; 2013 Dec; 27(6):559-63. PubMed ID: 23728885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced Molecular Knowledge of Therapeutic Drugs and Natural Products Focusing on Inflammatory Cytokines in Asthma.
    Lin SC; Shi LS; Ye YL
    Cells; 2019 Jul; 8(7):. PubMed ID: 31284537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From phenotypes to endotypes to asthma treatment.
    Agache IO
    Curr Opin Allergy Clin Immunol; 2013 Jun; 13(3):249-56. PubMed ID: 23587683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine and anti-cytokine therapy for asthma.
    Simon HU
    Curr Allergy Asthma Rep; 2006 Mar; 6(2):117-21. PubMed ID: 16566861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Personalized medicine with biologics for severe type 2 asthma: current status and future prospects.
    Godar M; Blanchetot C; de Haard H; Lambrecht BN; Brusselle G
    MAbs; 2018 Jan; 10(1):34-45. PubMed ID: 29035619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.